Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human PLA2G2A Antibody, R&D Systems™

Sheep Polyclonal Antibody
Supplier: R&D Systems AF5374SP
This item is not returnable.
View return policy
Description
PLA2G2A Polyclonal specifically detects PLA2G2A in Human samples. It is validated for Western Blot, Immunoprecipitation.Specifications
PLA2G2A | |
Polyclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
EC 3.1.1.4, GIIC sPLA2, Group IIA phospholipase A2, MOM1, Non-pancreatic secretory phospholipase A2, NPS-PLA2, Phosphatidylcholine 2-acylhydrolase 2A, phospholipase A2, group IIA (platelets, synovial fluid), phospholipase A2, membrane associated, PLA2B, PLA2BPLA2, PLA2L, PLA2LPLA2S, PLAS1, RASF-A, sPLA2 | |
Sheep | |
Affinity Purified | |
RUO | |
5320 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Western Blot, Immunoprecipitation | |
LYOPH | |
Western Blot 0.1 ug/mL, Immunoprecipitation 25 ug/mL | |
P14555 | |
PLA2G2A | |
S. frugiperda insect ovarian cell line Sf 21-derived recombinant human PLA2G2A Asn21-Cys144 Accession # P14555 | |
25 μg | |
Primary | |
Detects human PLA2G2A in direct ELISAs and Western blots. In Western blots, approximately 60% cross-reactivity with recombinant mouse PLA2G2A is observed and less than 5% cross-reactivity with recombinant human (rh) PLA2G1B and rhPLA2G7 is observed. | |
Human | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction